We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Retrieval Technique Simplifies Cancer Protein Research

By LabMedica International staff writers
Posted on 05 Aug 2010
New technology has been devised to retrieve better specific proteins needed to examine how cancer cells form by using a newly developed technique and synthetic nanopolymer. More...


Dr. W. Andy Tao, an assistant professor of biochemistry at Purdue University (West Lafayette, IN, USA), reported that these specific proteins, called phosphoproteins, can be mapped and examined so that investigators can find ways to suppress the processes that lead to cancer. But first, those few proteins must be picked out of a sea of thousands of others.

Dr. Tao developed and patented the polymer-based metal-ion affinity capture (PolyMAC) method. The synthetic nanopolymer isolates proteins and peptides that have undergone a process called phosphorylation that is highly associated with cancer, and a patented technique allows the retrieval of those proteins. Obtaining the information on these proteins is important for studying how to inhibit the processes that lead to cancer.

"You really want to capture these particular proteins, but there are so many different types of proteins around them,” said Dr. Tao, whose findings were published in July 2010 the early online version of the journal Molecular & Cellular Proteomics. "The target proteins are a thousand times lower in amount than other proteins. They are difficult to study without the capturing step.”

Normal cells grow, divide, and ultimately die. However, cancer cells continue to grow and do not die. Dr. Tao noted that phosphorylation--in which a type of enzyme called a kinase attaches to and catalyzes a protein on a cell--is believed in many cases to be responsible for creating cancer cells. Dr. Tao's nanopolymer is water-soluble and has titanium ions on its surface, which bind with phosphorylated proteins and peptides contained in a solution. The polymer also has a chemical group attached that is reactive and attached to small beads, which allow researchers to retrieve the polymers. "Once you put the nanopolymer in the solution, you have to retrieve them, so we put a handle on the polymer so we can grab on to it and fish it out of the solution,” Dr. Tao stated.

In laboratory tests, the nanopolymer and retrieval technique isolated approximately twice as many proteins that had been phosphorylated by an enzyme highly expressed in certain leukemia cells but absent in metastatic breast cancer cells.

Dr. Tao is now looking for ways to get the polymer and technique into wider use to aid in the development of new cancer drugs. "This technique is very useful and can be used widely in research for cancer as well as infectious diseases,” Dr. Tao concluded.

A US$1 million U.S. National Institutes of Health (Bethesda, MD, USA) grant under the American Reinvestment and Recovery Act paid for a mass spectrometer Dr. Tao utilizes to analyze and map the proteins he recovers using his nanopolymer and retrieval technique.

Related Links:

Purdue University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Immunofluorescence Analyzer
IFA System
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.